My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

    Howard BV, Best L, Comuzzie A, Ebbesson SO, Epstein SE, Fabsitz RR, Howard WJ, Silverman A, Wang H, Zhu J, Umans J.

    Diabetes Care. 2008 Dec;31(12):2312-4. Epub 2008 Sep 16.PMID: 18796618 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Diabetes mellitus and impaired fasting glucose in Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

    Carter EA, MacCluer JW, Dyke B, Howard BV, Devereux RB, Ebbesson SO, Resnick HE.

    Diabetologia. 2006 Jan;49(1):29-35. Epub 2005 Dec 21.PMID: 16369773 [PubMed - indexed for MEDLINE]Related articles

    3.

    Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.

    Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, Hanefeld M.

    Metabolism. 2002 Jun;51(6):743-9.PMID: 12037728 [PubMed - indexed for MEDLINE]Related articles

    4.

    Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis.

    Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ.

    Circulation. 2004 Aug 17;110(7):803-9. Epub 2004 Aug 2.PMID: 15289378 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

    Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM.

    Diabetes Care. 2002 Nov;25(11):2016-21.PMID: 12401749 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.

    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.

    Diabetes Care. 2007 Jan;30(1):113-9. Erratum in: Diabetes Care. 2007 Feb;30(2):455. PMID: 17192343 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

    Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT.

    Diabetologia. 2004 Aug;47(8):1403-10. Epub 2004 Jul 28.PMID: 15309290 [PubMed - indexed for MEDLINE]Related articles

    8.

    C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report.

    Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, Kang JH, Kim SW, Lee MH, Park JR.

    Int J Cardiol. 2004 Oct;97(1):101-6.PMID: 15336815 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events.

    Dai DF, Lin JW, Kao JH, Hsu CN, Chiang FT, Lin JL, Chou YH, Hsu KL, Tseng CD, Tseng YZ, Hwang JJ.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2532-7. Epub 2007 Apr 10.PMID: 17426096 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

    Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

    Diabetes. 2006 Aug;55(8):2357-64.PMID: 16873701 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

    Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM.

    Circulation. 2000 Jul 4;102(1):42-7.PMID: 10880413 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.

    Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW.

    Circulation. 2004 Jul 27;110(4):380-5. Epub 2004 Jul 19.PMID: 15262834 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Fatty acid consumption and metabolic syndrome components: the GOCADAN study.

    Ebbesson SO, Tejero ME, Nobmann ED, Lopez-Alvarenga JC, Ebbesson L, Romenesko T, Carter EA, Resnick HE, Devereux RB, MacCluer JW, Dyke B, Laston SL, Wenger CR, Fabsitz RR, Comuzzie AG, Howard BV.

    J Cardiometab Syndr. 2007 Fall;2(4):244-9.PMID: 18059206 [PubMed - indexed for MEDLINE]Related articles

    14.

    Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study.

    Nakanishi N, Shiraishi T, Wada M.

    Intern Med. 2005 Jun;44(6):542-7.PMID: 16020877 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adipokines, insulin resistance, and coronary artery calcification.

    Qasim A, Mehta NN, Tadesse MG, Wolfe ML, Rhodes T, Girman C, Reilly MP.

    J Am Coll Cardiol. 2008 Jul 15;52(3):231-6.PMID: 18617073 [PubMed - indexed for MEDLINE]Related articles

    16.

    Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?

    Bo S, Gambino R, Uberti B, Mangiameli MP, Colosso G, Repetti E, Gentile L, Cassader M, Pagano GF.

    Eur J Clin Invest. 2005 Apr;35(4):265-70.PMID: 15816996 [PubMed - indexed for MEDLINE]Related articles

    17.

    High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden.

    Ebrahimi A, Nabipour I, Vahdat K, Jafari SM, Fouladvand M, Assadi M, Movahed A, Obeidi N, Sanjdideh Z.

    Diabetes Res Clin Pract. 2009 Jun;84(3):296-302. Epub 2009 Apr 11.PMID: 19362745 [PubMed - indexed for MEDLINE]Related articles

    18.

    Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population.

    Muscari A, Antonelli S, Bianchi G, Cavrini G, Dapporto S, Ligabue A, Ludovico C, Magalotti D, Poggiopollini G, Zoli M; Pianoro Study Group.

    Diabetes Care. 2007 Sep;30(9):2362-8. Epub 2007 Jun 26.PMID: 17595349 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Evaluation of insulin resistance in normoglycemic patients with coronary artery disease.

    Deveci E, Yesil M, Akinci B, Yesil S, Postaci N, Arikan E, Koseoglu M.

    Clin Cardiol. 2009 Jan;32(1):32-6.PMID: 19143010 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).

    Muntner P, He J, Chen J, Fonseca V, Whelton PK.

    Ann Epidemiol. 2004 Oct;14(9):686-95.PMID: 15380800 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity